WILMINGTON, Del., Jan. 25, 2021 (GLOBE NEWSWIRE) —

Rigrodsky Law, P.A.

announces that it is investigating Obalon Therapeutics, Inc. (“Obalon”) (NASDAQ GS:

OBLN

) regarding possible breaches of fiduciary duties and other violations of law related to Obalon’s agreement to merge with ReShape Lifesciences, Inc.

To learn more about this investigation and your rights, visit:

https://www.rl-legal.com/cases-obalon-therapeutics-inc

.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or

[email protected]

.

Rigrodsky Law, P.A.

, with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in

securities fraud


and corporate class


actions

nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky Law, P.A.

Seth D. Rigrodsky

Gina M. Serra

(888) 969-4242 (Toll Free)

(302) 295-5310

Fax: (302) 654-7530


[email protected]



https://rl-legal.com